Credit Suisse’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-27,252
| Closed | -$37K | – | 3659 |
|
|
2016
Q4 | $37K | Sell |
27,252
-222,345
| -89% | -$302K | ﹤0.01% | 3683 |
|
|
2016
Q3 | $389K | Sell |
249,597
-64,584
| -21% | -$101K | ﹤0.01% | 3210 |
|
|
2016
Q2 | $418K | Buy |
314,181
+20,734
| +7% | +$27.6K | ﹤0.01% | 3227 |
|
|
2016
Q1 | $1.55M | Buy |
293,447
+72,466
| +33% | +$382K | ﹤0.01% | 2146 |
|
|
2015
Q4 | $1.74M | Sell |
220,981
-28,811
| -12% | -$226K | ﹤0.01% | 2200 |
|
|
2015
Q3 | $2.11M | Sell |
249,792
-37,811
| -13% | -$320K | ﹤0.01% | 2064 |
|
|
2015
Q2 | $3.15M | Buy |
287,603
+61,764
| +27% | +$676K | ﹤0.01% | 1970 |
|
|
2015
Q1 | $3.16M | Buy |
225,839
+46,309
| +26% | +$648K | ﹤0.01% | 1826 |
|
|
2014
Q4 | $3.03M | Buy |
179,530
+22,092
| +14% | +$373K | ﹤0.01% | 1900 |
|
|
2014
Q3 | $2.11M | Sell |
157,438
-204,520
| -57% | -$2.74M | ﹤0.01% | 2120 |
|
|
2014
Q2 | $4.61M | Sell |
361,958
-100,199
| -22% | -$1.28M | ﹤0.01% | 1738 |
|
|
2014
Q1 | $5.49M | Buy |
462,157
+117,906
| +34% | +$1.4M | 0.01% | 1466 |
|
|
2013
Q4 | $4.75M | Buy |
344,251
+128,925
| +60% | +$1.78M | ﹤0.01% | 1612 |
|
|
2013
Q3 | $3.75M | Buy |
215,326
+29,155
| +16% | +$508K | ﹤0.01% | 1593 |
|
|
2013
Q2 | $3.02M | Buy |
+186,171
| New | +$3.02M | ﹤0.01% | 1674 |
|